8 November 2011

The MedDRA Management Board met in Seville, Spain on 5 - 6 November 2011

The MedDRA Management Board is pleased to announce that the 2012 MSSO MedDRA subscription fees will remain the same as 2011. This is the 7th consecutive year that the subscription rates have not increased.

This was the fourth time the MedDRA Management Board hosted an open session to welcome the Regional Harmonisation Initiative and Drug Regulatory Authorities/Departments of Health members of the ICH Global Cooperation Group (GCG). Regulatory representatives of ICH and non-ICH regions shared their perspectives on the use of MedDRA in regulatory reporting and pharmacovigilance processes. Austrialian TGA, EMA, UK MHRA, and US FDA were among the presenters.

...

See the complete press release